MarketBeat
09 Aug 2026, 08:04 UTC · 1h ago
STERIS Q1 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
09 Aug 2026, 08:04 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
STERIS is investing $600 million in a new Formulated Chemistry Center of Excellence in North Carolina, its largest-ever single-site investment. — Significant capital commitment to scale production and R&D suggests long-term growth confidence and future efficiency gains via automation.
+0.40Adjusted diluted earnings per share rose 11% to $2.59 and the company maintained its full-year EPS guidance of $11.10 to $11.30. — Strong earnings growth and reaffirmed guidance provide stability and confidence in the company's financial trajectory.
+0.30Healthcare segment organic revenue grew 6%, driven by strong demand in ambulatory surgery centers and endoscopy due to increased cancer screenings. — Indicates strong organic demand in a core business vertical and suggests a structural tailwind from healthcare screening trends.
+0.20Continue reading
6 related stories
Top 3 movers · tap to explore
AST service volumes remained light as customers continued to reduce existing inventory, though normalization is expected in the second half. — Ongoing destocking acts as a temporary drag on growth and volume for the AST segment.
-0.20The company expects pretax restructuring charges of $55 million to $70 million related to the consolidation of existing chemistry facilities. — Represents a near-term hit to earnings, though it is a necessary cost for the long-term North Carolina project.
-0.10Which stocks this story touches
Reported revenue and earnings growth, expanded margins, and announced a major strategic investment in a new manufacturing complex.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
MarketBeat
3h ago
